Interleukin 6 and C-reactive protein levels in patients with acute allergic reactions: an emergency department-based study

被引:38
|
作者
Lin, RY
Trivino, MR
Curry, A
Pesola, GR
Knight, RJ
Lee, HS
Bakalchuk, L
Tenenbaum, C
Westfal, RE
机构
[1] St Vincents Hosp, Dept Med, New York, NY 10011 USA
[2] St Vincents Hosp, Dept Emergency Med, New York, NY 10011 USA
[3] New York Med Coll, Med Ctr, New York, NY USA
关键词
D O I
10.1016/S1081-1206(10)62923-7
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Elevations of interleukin 6 (IL-6) have been described in drug-induced anaphylaxis. Although IL-6 is well known to stimulate an acute phase response, profiling acute phase protein levels, such as C-reactive protein (CRP), has, to our knowledge, never been performed in patients with acute allergic reactions. Objective: To examine the pattern of IL-6 and CRP levels in patients with acute allergic reactions and to relate these to relevant clinical and laboratory parameters. Methods: Plasma CRP and serum IL-6 levels were determined in 85 adult emergency department patients. These patients had been previously studied with questionnaires, physical examinations, and histamine/tryptase levels. Clinical and historical features were related to CRP and IL-6 levels. CRP and IL-6 levels were also examined for relationships with histamine and tryptase levels. Results: CRP and IL-6 levels were significantly correlated with one another in the study patients (Spearman rho = 0.36, P = 0.0008). Similar to histamine levels, IL-6 levels were significantly correlated with the extent of erythema manifested by the study patients. The extent of erythema was independently predicted by both IL-6 and histamine levels. Histamine levels were negatively correlated with CRP levels (Spearman rho = -0.32, P = 0.003). Unlike histamine levels, IL-6 and CRP did not show significant relationships with the extent or presence of urticaria/angioedema or the presence of wheezing. IL-6 levels were correlated with the duration of symptoms before serologic sampling. An inverse correlation was observed between IL-6 levels and mean arterial blood pressure. Multivariate modeling showed significant independent effects from mean arterial pressure, duration of symptoms, erythema extent, and age in predicting IL-6 levels. Tryptase levels were higher in patients whose IL-6 levels were > 20 pg/mL. Conclusions: CRP and IL-6 levels are not simple surrogate markers for histamine or tryptase release by mast cells or basophils in acute allergic reactions. Increasing IL-6 levels relate to greater erythema extent, lower mean arterial blood pressure, and a longer duration of symptoms. It would be interesting to speculate that CRP and IL-6 increases characterize a late-phase response in immediate hypersensitivity reactions. In this perspective, the inverse relationship between CRP and histamine levels could be explained. As histamine levels are waning, CRP levels are increasing. Timed studies for histamine and CRP/IL-6 levels in allergic reactions are necessary to confirm this hypothesis.
引用
收藏
页码:412 / 416
页数:5
相关论文
共 50 条
  • [21] Interleukin-1 gene cluster and interleukin-6 gene polymorphisms and increase in C-reactive protein levels in patients with acute coronary syndrome
    Latkovskis, G
    Licis, N
    Juhnevica, D
    Jegere, S
    Maca, A
    Erglis, A
    Kalnins, U
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 88 - 88
  • [22] Risk stratification of emergency department patients with chest pain using C-reactive protein
    Manini, A. F.
    McAfee, A. T.
    Noble, V. E.
    Bohan, J. S.
    ANNALS OF EMERGENCY MEDICINE, 2006, 48 (04) : S28 - S28
  • [23] Prognostic value of mortality in emergency department sepsis score, procalcitonin, and C-reactive protein in patients with sepsis at the emergency department
    Lee, Chien-Chang
    Chen, Shey-Ying
    Tsai, Chu-Lin
    Wu, Shwu-Chong
    Chiang, Wen-Chu
    Wang, Jiun-Ling
    Sun, Hsin-Yun
    Chen, Shyr-Chyr
    Chen, Wen-Jone
    Hsueh, Po-Ren
    SHOCK, 2008, 29 (03): : 322 - 327
  • [24] Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
    Harris, TB
    Ferrucci, L
    Tracy, RP
    Corti, MC
    Wacholder, S
    Ettinger, WH
    Heimovitz, H
    Cohen, HJ
    Wallace, R
    AMERICAN JOURNAL OF MEDICINE, 1999, 106 (05): : 506 - 512
  • [25] Increased Levels of Circulating Interleukin 6, Interleukin 8, C-Reactive Protein, and Risk of Lung Cancer
    Pine, Sharon R.
    Mechanic, Leah E.
    Enewold, Lindsey
    Chaturvedi, Anil K.
    Katki, Hormuzd A.
    Zheng, Yun-Ling
    Bowman, Elise D.
    Engels, Eric A.
    Caporaso, Neil E.
    Harris, Curtis C.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (14): : 1112 - 1122
  • [26] Plasma interleukin-6 and C-reactive protein levels in chronic myeloproliferative diseases
    Pogliani, E
    Bregani, R
    Mozzanica, M
    Corneo, G
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 895 - 895
  • [27] Serum interleukin 6 (IL-6) and C-reactive protein (CRP) levels in colorectal adenoma and cancer patients
    Groblewska, Magdalena
    Mroczko, Barbara
    Wereszczynska-Siemiatkowska, Urszula
    Kedra, Boguslaw
    Lukaszewicz, Marta
    Baniukiewicz, Andrzej
    Szmitkowski, Maciej
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2008, 46 (10) : 1423 - 1428
  • [28] Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer
    Petrovic, Marina
    Cekerevac, Ivan
    Kostic, Gordana
    Cupic, Violeta Iric
    Davidovic, Goran
    Lazic, Zorica
    Cupurdija, Vojislav
    Novkovic, Ljiljana
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [29] Rofecoxib, a COX-2 inhibitor, lowers C-reactive protein and interleukin-6 levels in patients with acute coronary syndromes
    Monakier, D
    Mates, M
    Klutstein, MW
    Balkin, JA
    Rudensky, B
    Meerkin, D
    Tzivoni, D
    CHEST, 2004, 125 (05) : 1610 - 1615
  • [30] PLASMA INTERLEUKIN-6 AND C-REACTIVE PROTEIN-LEVELS IN REACTIVE VERSUS CLONAL THROMBOCYTOSIS
    TEFFERI, A
    HO, TC
    AHMANN, GJ
    KATZMANN, JA
    GREIPP, PR
    AMERICAN JOURNAL OF MEDICINE, 1994, 97 (04): : 374 - 378